For individuals managing diabetes, achieving consistent glycemic control is a daily balancing act. The introduction of premixed insulin analogs has revolutionized this process, offering a simplified yet effective approach. Among these, the Humalog 100IU Mix-50 Refill Cartridge (3mL) stands out as a sophisticated therapeutic tool from Eli Lilly and Company. This product embodies a commitment to combining pharmaceutical innovation with practical patient-centered design. It is specifically formulated for use with compatible Lilly insulin pen devices, providing a convenient and precise method for delivering a fixed-ratio combination of two distinct insulin analogs. This detailed description explores the science, benefits, and practical applications of this critical diabetes management medication.
The Humalog 100IU Mix-50 Refill Cartridge contains a uniform suspension of two insulin analogs in a predefined proportion:
50% Insulin Lispro Protamine Suspension: This component acts as an intermediate-acting insulin. The protamine complex delays absorption, providing a basal level of insulin that mimics the body's background insulin secretion. This helps control blood glucose levels between meals and overnight.
50% Insulin Lispro Injection: This is a rapid-acting insulin analog. It is absorbed quickly from the subcutaneous tissue, beginning to lower blood glucose within approximately 15 minutes of injection. Its peak activity occurs around 30 minutes to 2.5 hours, effectively targeting the sharp rise in glucose that follows a meal (postprandial glucose).
This fixed 50/50 ratio is designed to address both prandial (meal-time) and basal (background) insulin needs in a single injection. It offers a streamlined regimen for patients who require both types of insulin but seek to minimize the number of daily injections and complex calculations associated with a basal-bolus regimen.
1. Enhanced Postprandial Glucose Control:
The rapid-acting Insulin Lispro component is engineered to have a faster onset and a more physiological profile compared to regular human insulin. This allows patients to inject closer to mealtime (within 15 minutes before or immediately after a meal), offering greater flexibility and more effective management of meal-related blood sugar spikes.
2. Simplified Regimen for Improved Adherence:
Managing multiple vials, calculating ratios, and administering several injections daily can lead to "therapy fatigue." The premixed nature of Humalog Mix-50 consolidates therapy into fewer injections, significantly simplifying the regimen. Improved adherence is directly linked to better long-term glycemic outcomes and a reduced risk of complications.
3. Predictable and Sustained Action Profile:
The intermediate-acting protamine suspension component provides a prolonged duration of action, typically up to 24 hours, depending on the individual. This predictable basal coverage helps maintain stable glucose levels outside of meal times.
4. Precision Dosing with Pen Compatibility:
The 3mL refill cartridge is designed for use with specific, reusable Lilly insulin pen devices (consult with your healthcare provider or pharmacist for compatible models). Pen devices offer discrete, convenient, and accurate dosing, often with audible clicks and clear dose windows, reducing the potential for dosing errors associated with traditional syringes and vials.
5. Trusted Eli Lilly Quality and Manufacturing:
As a product from a global leader in diabetes care, Humalog Mix-50 is manufactured under stringent quality controls. Lilly's decades of research and development in insulin analogs ensure a high-purity, consistent, and reliable product for patients worldwide.
The Humalog Mix-50 Refill Cartridge is indicated to improve glycemic control in:
Adults and children with type 1 diabetes mellitus, typically as part of a regimen that may include a longer-acting basal insulin.
Adults with type 2 diabetes mellitus who require insulin therapy. It is often an excellent option for patients transitioning from oral medications or using a single daily injection of a longer-acting insulin who are not achieving target A1c levels, particularly due to high postprandial glucose.
It is crucial to note that premixed insulins like Mix-50 require a consistent daily routine regarding meal timing, carbohydrate intake, and physical activity due to their fixed ratio.
Dosage: Highly individualized. Determined by the healthcare provider based on metabolic needs, blood glucose monitoring results, and glycemic control goals. It is typically administered twice daily (before breakfast and before dinner).
Administration: For subcutaneous use only. The cartridge must be gently rolled (not shaken) between the palms 10 times and tipped upside down 10 times to ensure complete resuspension until the liquid appears uniformly cloudy or milky. Failure to resuspend properly can lead to inaccurate dosing.
Contraindications: During episodes of hypoglycemia and in patients hypersensitive to Insulin Lispro or any of the excipients.
Warnings and Precautions:
Hypoglycemia is the most common adverse reaction. Risk increases with changes in meal pattern, physical activity, and concomitant medications.
Never share an insulin pen or cartridge between patients, even with needle changes, due to the risk of bloodborne pathogen transmission.
As with all insulins, injection site reactions (lipodystrophy, redness, itching) may occur. Rotating injection sites is essential.
Close monitoring of blood glucose is required, especially when changing therapy, during illness, or when there is a change in lifestyle.
Storage: Unopened (unused) cartridges should be stored refrigerated at 2°C to 8°C (36°F to 46°F). Do not freeze. Once punctured and in use, the cartridge can be kept at room temperature (below 30°C/86°F) for up to 28 days. It should not be refrigerated while in use. Protect from excessive heat and light.
The Humalog 100IU Mix-50 Refill Cartridge (3mL) represents a thoughtful fusion of advanced insulin analog science and practical therapy management. By delivering rapid-onset and intermediate-acting insulin in one predictable formulation, it addresses a fundamental need in diabetes care: effective control with streamlined convenience. For eligible patients with type 1 or type 2 diabetes, it can be a powerful tool to reduce injection burden, improve regimen adherence, and achieve better overall postprandial and daily glucose control.
On all orders is set at $25.00
Protected by Bitcoin
On all huge orders